Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors

G. T. Somogyi, E. Vízi

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The release of 3H-acetylcholine (ACh) from longitudinal muscle strips of guinea pig ileum, which were previously incubated with 3H-choline, was measured by scintillation spectrometry. The release of ACh evoked by electrical field stimulation was inhibited in the following ways: stimulating muscarinic receptors directly with oxotremorine or indirectly with eserine by increasing ACh concentration in the surrounding axon terminals or stimulating adenosine receptors by increasing the biophase concentration of adenosine with dipyridamole. The muscarinic antagonist atropine and the adenosine receptor antagonist theophylline enhanced ACh release. Atropine prevented the effect of eserine and oxotremorine on ACh release and theophylline counteracted the effect of dipyridamole. When the release of ACh was under the inhibitory effect ofmuscarininc receptor stimulation theophylline did not increase ACh release. Under these conditions atropine caused an extremely high increase in the release of ACh, which was not further enhanced by theophylline. When the extracellular level of adenosine was increased by dipyridamole, eserine, atropine or eserine and atropine together, they were unable to change the release of ACh, while theophylline increased release of ACh. Therefore, it is concluded that the muscarinic receptor mediated inhibition of ACh release is not due to previously released adenosine. Thus, adenosine and muscarinic feedback systems seem to be independent and each cholinergic nerve ending contains both adenosine and muscarinic receptors.

Original languageEnglish
Pages (from-to)575-579
Number of pages5
JournalBrain Research Bulletin
Volume21
Issue number4
DOIs
Publication statusPublished - 1988

Fingerprint

Purinergic P1 Receptors
Presynaptic Terminals
Muscarinic Receptors
Cholinergic Agents
Acetylcholine
Theophylline
Atropine
Physostigmine
Adenosine
Dipyridamole
Oxotremorine
Purinergic P1 Receptor Antagonists
Muscarinic Antagonists
Nerve Endings
Choline
Ileum
Electric Stimulation
Spectrum Analysis
Guinea Pigs

Keywords

  • Acetyleholine
  • Cholinergic transmission
  • Dipyridamole
  • Feedback regulation
  • Theopylline

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors. / Somogyi, G. T.; Vízi, E.

In: Brain Research Bulletin, Vol. 21, No. 4, 1988, p. 575-579.

Research output: Contribution to journalArticle

@article{5e04f9548a954c42a45ed3f051fea6e1,
title = "Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors",
abstract = "The release of 3H-acetylcholine (ACh) from longitudinal muscle strips of guinea pig ileum, which were previously incubated with 3H-choline, was measured by scintillation spectrometry. The release of ACh evoked by electrical field stimulation was inhibited in the following ways: stimulating muscarinic receptors directly with oxotremorine or indirectly with eserine by increasing ACh concentration in the surrounding axon terminals or stimulating adenosine receptors by increasing the biophase concentration of adenosine with dipyridamole. The muscarinic antagonist atropine and the adenosine receptor antagonist theophylline enhanced ACh release. Atropine prevented the effect of eserine and oxotremorine on ACh release and theophylline counteracted the effect of dipyridamole. When the release of ACh was under the inhibitory effect ofmuscarininc receptor stimulation theophylline did not increase ACh release. Under these conditions atropine caused an extremely high increase in the release of ACh, which was not further enhanced by theophylline. When the extracellular level of adenosine was increased by dipyridamole, eserine, atropine or eserine and atropine together, they were unable to change the release of ACh, while theophylline increased release of ACh. Therefore, it is concluded that the muscarinic receptor mediated inhibition of ACh release is not due to previously released adenosine. Thus, adenosine and muscarinic feedback systems seem to be independent and each cholinergic nerve ending contains both adenosine and muscarinic receptors.",
keywords = "Acetyleholine, Cholinergic transmission, Dipyridamole, Feedback regulation, Theopylline",
author = "Somogyi, {G. T.} and E. V{\'i}zi",
year = "1988",
doi = "10.1016/0361-9230(88)90195-5",
language = "English",
volume = "21",
pages = "575--579",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors

AU - Somogyi, G. T.

AU - Vízi, E.

PY - 1988

Y1 - 1988

N2 - The release of 3H-acetylcholine (ACh) from longitudinal muscle strips of guinea pig ileum, which were previously incubated with 3H-choline, was measured by scintillation spectrometry. The release of ACh evoked by electrical field stimulation was inhibited in the following ways: stimulating muscarinic receptors directly with oxotremorine or indirectly with eserine by increasing ACh concentration in the surrounding axon terminals or stimulating adenosine receptors by increasing the biophase concentration of adenosine with dipyridamole. The muscarinic antagonist atropine and the adenosine receptor antagonist theophylline enhanced ACh release. Atropine prevented the effect of eserine and oxotremorine on ACh release and theophylline counteracted the effect of dipyridamole. When the release of ACh was under the inhibitory effect ofmuscarininc receptor stimulation theophylline did not increase ACh release. Under these conditions atropine caused an extremely high increase in the release of ACh, which was not further enhanced by theophylline. When the extracellular level of adenosine was increased by dipyridamole, eserine, atropine or eserine and atropine together, they were unable to change the release of ACh, while theophylline increased release of ACh. Therefore, it is concluded that the muscarinic receptor mediated inhibition of ACh release is not due to previously released adenosine. Thus, adenosine and muscarinic feedback systems seem to be independent and each cholinergic nerve ending contains both adenosine and muscarinic receptors.

AB - The release of 3H-acetylcholine (ACh) from longitudinal muscle strips of guinea pig ileum, which were previously incubated with 3H-choline, was measured by scintillation spectrometry. The release of ACh evoked by electrical field stimulation was inhibited in the following ways: stimulating muscarinic receptors directly with oxotremorine or indirectly with eserine by increasing ACh concentration in the surrounding axon terminals or stimulating adenosine receptors by increasing the biophase concentration of adenosine with dipyridamole. The muscarinic antagonist atropine and the adenosine receptor antagonist theophylline enhanced ACh release. Atropine prevented the effect of eserine and oxotremorine on ACh release and theophylline counteracted the effect of dipyridamole. When the release of ACh was under the inhibitory effect ofmuscarininc receptor stimulation theophylline did not increase ACh release. Under these conditions atropine caused an extremely high increase in the release of ACh, which was not further enhanced by theophylline. When the extracellular level of adenosine was increased by dipyridamole, eserine, atropine or eserine and atropine together, they were unable to change the release of ACh, while theophylline increased release of ACh. Therefore, it is concluded that the muscarinic receptor mediated inhibition of ACh release is not due to previously released adenosine. Thus, adenosine and muscarinic feedback systems seem to be independent and each cholinergic nerve ending contains both adenosine and muscarinic receptors.

KW - Acetyleholine

KW - Cholinergic transmission

KW - Dipyridamole

KW - Feedback regulation

KW - Theopylline

UR - http://www.scopus.com/inward/record.url?scp=0024160771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024160771&partnerID=8YFLogxK

U2 - 10.1016/0361-9230(88)90195-5

DO - 10.1016/0361-9230(88)90195-5

M3 - Article

VL - 21

SP - 575

EP - 579

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 4

ER -